Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion type Assertion NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_head.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion description "[Considering the possible role of Prx1 and Nrf2 in radioresistance/chemoresistance, it warrants future investigation to evaluate whether elevated Prx1 and/or Nrf2 levels are predictive of treatment response in advanced lung cancer and other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_provenance.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion evidence source_evidence_literature NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_provenance.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion SIO_000772 17606720 NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_provenance.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion wasDerivedFrom befree-20150227 NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_provenance.
- NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_assertion wasGeneratedBy ECO_0000203 NP606303.RASchoV2dIuqRfl9ppKy-lQLLQF7LZzl-AmgtGtTO7YQY130_provenance.